Eddie Reed

8.1k total citations · 1 hit paper
144 papers, 5.4k citations indexed

About

Eddie Reed is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Eddie Reed has authored 144 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 73 papers in Molecular Biology, 58 papers in Oncology and 26 papers in Cancer Research. Recurrent topics in Eddie Reed's work include DNA Repair Mechanisms (26 papers), Cancer Treatment and Pharmacology (18 papers) and Prostate Cancer Treatment and Research (13 papers). Eddie Reed is often cited by papers focused on DNA Repair Mechanisms (26 papers), Cancer Treatment and Pharmacology (18 papers) and Prostate Cancer Treatment and Research (13 papers). Eddie Reed collaborates with scholars based in United States, China and Malaysia. Eddie Reed's co-authors include Qingdi Li, Gangduo Wang, William D. Figg, Tito Fojo, R. R. Parker, Manuel Álvarez, K Paull, Waldo Ortuzar, Olivier Rixe and Bing‐Hua Jiang and has published in prestigious journals such as Journal of Biological Chemistry, Journal of Clinical Oncology and Nature Biotechnology.

In The Last Decade

Eddie Reed

140 papers receiving 5.3k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Oxaliplatin, tetraplatin, cisplatin, and carboplatin: Spectrum of activity in drug-resistant cell lines and in the cell lines of the national cancer institute's anticancer drug screen panel

1996 510 citations Eddie Reed, Tito Fojo et al. Biochemical Pharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Eddie Reed United States	43	2.9k	2.0k	987	727	625	144	5.4k
Peter Nygren Sweden	47	2.8k 1.0×	2.7k 1.4×	885 0.9×	768 1.1×	493 0.8×	234	7.0k
Sharon Marsh United States	43	2.9k 1.0×	3.0k 1.5×	708 0.7×	648 0.9×	587 0.9×	109	6.7k
John F. Smyth United Kingdom	52	3.7k 1.3×	2.9k 1.5×	921 0.9×	544 0.7×	693 1.1×	202	8.2k
Guido Bocci Italy	42	2.4k 0.8×	2.6k 1.3×	1.2k 1.2×	1.0k 1.4×	400 0.6×	206	5.8k
Annette K. Larsen France	43	3.7k 1.3×	2.6k 1.3×	1.0k 1.0×	814 1.1×	815 1.3×	161	6.9k
Nanno H. Mulder Netherlands	43	2.2k 0.8×	3.4k 1.7×	592 0.6×	935 1.3×	697 1.1×	229	6.9k
Alfonso Dueñas‐González Mexico	44	3.0k 1.0×	1.1k 0.6×	827 0.8×	547 0.8×	255 0.4×	171	5.8k
Alan V. Boddy United Kingdom	41	2.4k 0.9×	2.2k 1.1×	465 0.5×	670 0.9×	840 1.3×	188	5.9k
Massimo Zucchetti Italy	40	1.8k 0.6×	1.9k 0.9×	421 0.4×	579 0.8×	308 0.5×	170	4.8k
Kenneth K. Chan United States	47	5.0k 1.8×	1.3k 0.7×	1.5k 1.5×	386 0.5×	500 0.8×	172	8.1k

Countries citing papers authored by Eddie Reed

Since Specialization

Citations

This map shows the geographic impact of Eddie Reed's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eddie Reed with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eddie Reed more than expected).

Fields of papers citing papers by Eddie Reed

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Eddie Reed. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eddie Reed. The network helps show where Eddie Reed may publish in the future.

Co-authorship network of co-authors of Eddie Reed

This figure shows the co-authorship network connecting the top 25 collaborators of Eddie Reed. A scholar is included among the top collaborators of Eddie Reed based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Eddie Reed. Eddie Reed is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Meng, Erhong, Aparna Mitra, Kaushlendra Tripathi, et al.. (2014). ALDH1A1 Maintains Ovarian Cancer Stem Cell-Like Properties by Altered Regulation of Cell Cycle Checkpoint and DNA Repair Network Signaling. PLoS ONE. 9(9). e107142–e107142. 127 indexed citations

Nicholls, Keith W., et al.. (2011). Enhancing Response Rates in Physician Surveys: The Limited Utility of Electronic Options. Health Services Research. 46(5). 1675–1682. 48 indexed citations

Gao, Rui, Douglas K. Price, William L. Dahut, Eddie Reed, & William D. Figg. (2010). Genetic polymorphisms in XRCC1 associated with radiation therapy in prostate cancer. Cancer Biology & Therapy. 10(1). 13–18. 31 indexed citations

Yan, Qing-Wu, et al.. (2006). MZF1 possesses a repressively regulatory function in ERCC1 expression. Biochemical Pharmacology. 71(6). 761–771. 33 indexed citations

Zhang, Peilin, et al.. (2005). Inducible degradation of checkpoint kinase 2 links to cisplatin-induced resistance in ovarian cancer cells. Biochemical and Biophysical Research Communications. 328(2). 567–572. 21 indexed citations

Seiden, Michael V., Alan N. Gordon, Diane C. Bodurka, et al.. (2005). A phase II study of irofulven in women with recurrent and heavily pretreated ovarian cancer. Gynecologic Oncology. 101(1). 55–61. 23 indexed citations

Wang, Gangduo, Xiping Li, Furong Huang, et al.. (2004). Elemene, a novel anticancer drug, triggers cell death and enhances cisplatin sensitivity via induction of apoptosis and cell cycle arrest in human non-small cell lung cancer cells. Cancer Research. 64. 689–689. 1 indexed citations

Altaha, Ramin, Tito Fojo, Eddie Reed, & Jame Abraham. (2002). Epothilones: A Novel Class of Non-taxane Microtubule-stabilizing Agents. Current Pharmaceutical Design. 8(19). 1707–1712. 48 indexed citations

Rudek, Michelle A., McDonald K. Horne, William D. Figg, et al.. (2001). Reversible sideroblastic anemia associated with the tetracycline analogue COL‐3. American Journal of Hematology. 67(1). 51–53. 13 indexed citations

10.

Shapiro, Jeremy, Mace L. Rothenberg, Gisele Sarosy, et al.. (1998). Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer. Cancer. 83(9). 1980–1988. 1 indexed citations

11.

Shapiro, Jeremy, M.L. Rothenberg, Gisele Sarosy, et al.. (1998). Dose intensive combination platinum and cyclophosphamide in the treatment of patients with advanced untreated epithelial ovarian cancer. Cancer. 83(9). 1980–1988. 17 indexed citations

12.

Dixon, Shannon C., et al.. (1998). Methods for extracting and amplifying genomic DNA isolated from frozen serum. Nature Biotechnology. 16(1). 91–94. 35 indexed citations

13.

Buell, Joseph F., et al.. (1997). Synergistic effect and possible mechanisms of tumor necrosis factor and cisplatin cytotoxicity under moderate hyperthermia against gastric cancer cells. Annals of Surgical Oncology. 4(2). 141–148. 22 indexed citations

14.

Figg, William D., Nancy A. Dawson, Otis W. Brawley, et al.. (1996). Flutamide Withdrawal and Concomitant Initiation of Aminoglutethimide in Patients with Hormone Refractory Prostate Cancer. Acta Oncologica. 35(6). 763–765. 8 indexed citations

15.

Krantz, David S., et al.. (1996). The impact of disease severity on the informed consent process in clinical research. The American Journal of Medicine. 100(3). 261–268. 140 indexed citations

16.

Wang, Zheng, et al.. (1996). Sensitization by interleukin-lα of carboplatinum anti-tumor activity against human ovarian (NIH:OVCAR-3) carcinoma cellsin vitro andin vivo. International Journal of Cancer. 68(5). 583–587. 7 indexed citations

17.

Figg, William D., Nancy A. Dawson, Oliver Sartor, et al.. (1996). A phase I/II study of continuous infusion suramin in patients with hormone-refractory prostate cancer : toxicity and response. Cancer Chemotherapy and Pharmacology. 39(1-2). 1–8. 34 indexed citations

18.

Reed, Eddie, Michael R. Cooper, Renato V. LaRocca, Benjamín C. Bostick, & Charles E. Myers. (1992). Suramin in advanced platinum-resistant ovarian cancer. European Journal of Cancer. 28(4-5). 864–866. 17 indexed citations

19.

Parker, R. J., Robert E. Tarone, Justine Vionnet, et al.. (1991). Platinum—DNA damage in leukocyte DNA of patients receiving carboplatin and cisplatin chemotherapy, measured by atomic absorption spectrometry. Carcinogenesis. 12(7). 1253–1258. 66 indexed citations

20.

Dabholkar, Meenakshi, Alan Eastman, & Eddie Reed. (1990). Host-cell reactivation of cisplatin-damaged pRSVcat in a human lymphoid cell line. Carcinogenesis. 11(10). 1761–1764. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact